Absci and AMD Announce Collaboration and Strategic Investment …
3 days ago · Absci intends these forward-looking statements, including express or implied statements regarding acceleration of the future of AI drug discovery, Absci’s leadership in AI drug discovery, Absci’s ability to leverage AMD’s equity investment, and Absci’s ability to create better biologics and develop next generation antibody therapeutics ...
Small-Cap Biotech Absci Draws Heavy Attention On $20M AMD …
11 hours ago · The investment reportedly marks AMD’s entry into life sciences, leveraging its AI chips for drug discovery. ... DTIL 37.78%. ROKU 3.18%. PLTR 1.82%. More. Home · News · Markets · Equity · Small-Cap Biotech Absci Draws Heavy Attention On $20M AMD Investment Pledge, Retail's Bullish Despite Pre-Market Dip. Small-Cap Biotech Absci Draws ...
Absci and AMD Announce Collaboration and Strategic Investment …
2 days ago · $20 Million Equity Investment from AMD Strengthens Absci’s Leadership in AI Drug Discovery and Further Expands Biopharma Adoption of AMD Instinct Accelerators and ROCm SoftwareVANCOUVER, Wash ...
Absci Stock Jumps As AMD Invests $20M To Boost AI Drug …
2 days ago · Absci Stock Jumps As AMD Invests $20M To Boost AI Drug Discovery. AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the company ...
Absci Corporation Announces Strategic Collaboration with AMD …
2 days ago · Absci partners with AMD, investing $20 million to enhance AI-driven drug discovery and antibody design capabilities. Quiver AI Summary. Absci Corporation has announced a strategic partnership with ...
Absci Announces Strategic Collaboration With AMD To Advance …
2 days ago · AMD will also invest $20 million in Absci through a PIPE (Private Investment in Public Equity), highlighting the increasing demand for innovative AI applications in drug discovery.
Absci Stock Jumps As AMD Invests $20M To Boost AI Drug …
2 days ago · AMD’s support will enable Absci to enhance its proprietary antibody design model, IgDesign1, which is the first in vitro validated inverse folding model for antibody design. ... Market News and ...
Absci Secures $20M AMD Investment, Strategic AI Drug Discovery ...
2 days ago · Absci (NASDAQ: ABSI) has announced a strategic collaboration with AMD focused on AI drug discovery advancement. The partnership includes a $20 million strategic investment from AMD through a private investment in public equity (PIPE) and will involve deploying AMD Instinct™ accelerators and ROCm™ software to power Absci's AI drug discovery workloads, including de novo antibody design models.
Absci, AMD announce collaboration, strategic investment
2 days ago · AMD will also make a $20M investment in Absci, structured as a private investment in public equity, PIPE, underscoring the growing demand for innovative AI applications in drug discovery.
AMD Invests in Drug-Discovery Company Absci in Push to Sell AI …
Advanced Micro Devices is investing $20 million in Absci, a drug-discovery company based in Washington state, in a move aimed at selling its artificial intelligence chips in the healthcare sector ...
- Some results have been removed